Pfizer, Inc.
I · AI Analysis
The brief
Pfizer discovers, develops, and sells prescription medicines across multiple areas including heart disease drugs (Eliquis), cancer treatments (Ibrance, Xtandi), vaccines (Prevnar, Abrysvo), and COVID-19 treatment (Paxlovid) [Company Overview]. They also make treatments for rare diseases, immune disorders, and biosimilar versions of other companies' drugs, selling their products in the United States and internationally [Company Overview].
Pfizer is a 175-year-old pharmaceutical giant based in New York that makes and sells medicines, vaccines, and treatments worldwide. The company has a $155.6 billion market cap but is currently facing revenue decline and moderate financial health concerns [Yahoo Finance].
Pfizer generates substantial revenue and cash flow but shows declining sales and moderate financial stress signals.
Sentinellis health
5.3/10
Moderate concerns
Market capitalisation
$155.6B
Revenue (TTM)
$62.6B
II · Recent news
What moved
6 stories · ranked by relevance
- macro2026-04-16
Pfizer Inc. $PFE Shares Acquired by United Advisor Group LLC
Watch List News
- macro2026-04-16
Here Are Thursday’s Top Wall Street Analyst Research Calls: Autoliv, CoreWeave, Corning, Dicks Sporting Goods, Federated Hermes, Gitlab, PayPal, Pfizer, Okta, and More
24/7 Wall St
- macro2026-04-16
KBC Group NV Purchases 706,426 Shares of Pfizer Inc. $PFE
The Lincolnian Online
- macro2026-04-16
Best Pharmaceutical Stocks To Watch Now – April 15th
The Lincolnian Online
- macro2026-04-16
Lbp Am Sa Has $25.32 Million Holdings in Pfizer Inc. $PFE
The Lincolnian Online
- macro2026-04-16
Pfizer Inc. $PFE Shares Sold by Transcend Capital Advisors LLC
Watch List News
Premium · Free with any account
Revenue is declining rather than growing, down 1.2% year-over-year, which suggests the company is losing sales momentum [Yahoo Finance]
Risks
5
Opportunities
5
Red flags
4
Leadership
10
13 more findings in the full report — free with any account.
Unlock the full Pfizer, Inc. analysis
Create a free account to access the complete AI-generated report with inline citations.
- 5 risks, 5 opportunities and 4 red flags — each with its source
- 100+ financial metrics with charts and benchmarks
- Full news summaries with source links
- Executive team and compensation details
- PDF export for offline use
III · Related
You might also read
Same sector · Healthcare or comparable health
Want this for your watchlist?